Top Markets
#1 Islamic Coin Islamic Coin +151.54%
#2 Akedo Akedo +68.63%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.64%
#5 Velvet Velvet +39.32%
#6 Black Phoenix Black Phoenix +34.14%
#7 Cross Cross +31.00%
#8 Cap Cap +18.34%
#9 DoubleZero DoubleZero +13.97%
#10 Pieverse Pieverse +10.78%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Burzynski Research Institute, Inc. Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc.

BZYR
Rank in Stocks #39233
Burzynski Research Institute, Inc. engages in the research and development of... Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Share Price
$0.0045
Last synced: 2026-08-13
Market Cap
$591.52K
Change (1 day)
-10.00%
Change (1 year)
-86.76%
Country
US
Trade Burzynski Research Institute, Inc. (BZYR)

Category

Healthcare
Number of shares outstanding for Burzynski Research Institute, Inc. (BZYR)
Number of shares outstanding as of August 2026: 0
According to Burzynski Research Institute, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Burzynski Research Institute, Inc. (BZYR) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 445.06M -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 105.38M -
US